Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair

Introduction: Currently, there are no non-surgical FDA-approved biological approaches to accelerate fracture repair. Injectable therapies designed to stimulate bone healing represent an exciting alternative to surgically implanted biologics, however, the translation of effective osteoinductive thera...

Full description

Bibliographic Details
Main Authors: Kevin O. Rivera, Darnell L. Cuylear, Victoria R. Duke, Kelsey M. O’Hara, Justin X. Zhong, Nafisa A. Elghazali, Joel A. Finbloom, Bhushan N. Kharbikar, Alex N. Kryger, Theodore Miclau, Ralph S. Marcucio, Chelsea S. Bahney, Tejal A. Desai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1190371/full
_version_ 1797822243924869120
author Kevin O. Rivera
Kevin O. Rivera
Kevin O. Rivera
Darnell L. Cuylear
Darnell L. Cuylear
Victoria R. Duke
Kelsey M. O’Hara
Justin X. Zhong
Justin X. Zhong
Nafisa A. Elghazali
Nafisa A. Elghazali
Joel A. Finbloom
Bhushan N. Kharbikar
Alex N. Kryger
Theodore Miclau
Ralph S. Marcucio
Chelsea S. Bahney
Chelsea S. Bahney
Chelsea S. Bahney
Chelsea S. Bahney
Tejal A. Desai
Tejal A. Desai
Tejal A. Desai
Tejal A. Desai
author_facet Kevin O. Rivera
Kevin O. Rivera
Kevin O. Rivera
Darnell L. Cuylear
Darnell L. Cuylear
Victoria R. Duke
Kelsey M. O’Hara
Justin X. Zhong
Justin X. Zhong
Nafisa A. Elghazali
Nafisa A. Elghazali
Joel A. Finbloom
Bhushan N. Kharbikar
Alex N. Kryger
Theodore Miclau
Ralph S. Marcucio
Chelsea S. Bahney
Chelsea S. Bahney
Chelsea S. Bahney
Chelsea S. Bahney
Tejal A. Desai
Tejal A. Desai
Tejal A. Desai
Tejal A. Desai
author_sort Kevin O. Rivera
collection DOAJ
description Introduction: Currently, there are no non-surgical FDA-approved biological approaches to accelerate fracture repair. Injectable therapies designed to stimulate bone healing represent an exciting alternative to surgically implanted biologics, however, the translation of effective osteoinductive therapies remains challenging due to the need for safe and effective drug delivery. Hydrogel-based microparticle platforms may be a clinically relevant solution to create controlled and localized drug delivery to treat bone fractures. Here, we describe poly (ethylene glycol) dimethacrylate (PEGDMA)-based microparticles, in the shape of microrods, loaded with beta nerve growth factor (β-NGF) for the purpose of promoting fracture repair.Methods: Herein, PEGDMA microrods were fabricated through photolithography. PEGDMA microrods were loaded with β-NGF and in vitro release was examined. Subsequently, bioactivity assays were evaluated in vitro using the TF-1 tyrosine receptor kinase A (Trk-A) expressing cell line. Finally, in vivo studies using our well-established murine tibia fracture model were performed and a single injection of the β-NGF loaded PEGDMA microrods, non-loaded PEGDMA microrods, or soluble β-NGF was administered to assess the extent of fracture healing using Micro-computed tomography (µCT) and histomorphometry.Results:In vitro release studies showed there is significant retention of protein within the polymer matrix over 168 hours through physiochemical interactions. Bioactivity of protein post-loading was confirmed with the TF-1 cell line. In vivo studies using our murine tibia fracture model show that PEGDMA microrods injected at the site of fracture remained adjacent to the callus for over 7 days. Importantly, a single injection of β-NGF loaded PEGDMA microrods resulted in improved fracture healing as indicated by a significant increase in the percent bone in the fracture callus, trabecular connective density, and bone mineral density relative to soluble β-NGF control indicating improved drug retention within the tissue. The concomitant decrease in cartilage fraction supports our prior work showing that β-NGF promotes endochondral conversion of cartilage to bone to accelerate healing.Discussion: We demonstrate a novel and translational method wherein β-NGF can be encapsulated within PEGDMA microrods for local delivery and that β-NGF bioactivity is maintained resulting in improved bone fracture repair.
first_indexed 2024-03-13T10:05:09Z
format Article
id doaj.art-2d67733dedb841e4b0796fa4acfa384e
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-03-13T10:05:09Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-2d67733dedb841e4b0796fa4acfa384e2023-05-22T14:45:23ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-05-011110.3389/fbioe.2023.11903711190371Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repairKevin O. Rivera0Kevin O. Rivera1Kevin O. Rivera2Darnell L. Cuylear3Darnell L. Cuylear4Victoria R. Duke5Kelsey M. O’Hara6Justin X. Zhong7Justin X. Zhong8Nafisa A. Elghazali9Nafisa A. Elghazali10Joel A. Finbloom11Bhushan N. Kharbikar12Alex N. Kryger13Theodore Miclau14Ralph S. Marcucio15Chelsea S. Bahney16Chelsea S. Bahney17Chelsea S. Bahney18Chelsea S. Bahney19Tejal A. Desai20Tejal A. Desai21Tejal A. Desai22Tejal A. Desai23Graduate Program in Oral and Craniofacial Sciences, School of Dentistry, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Orthopaedic Surgery, Orthopaedic Trauma Institute, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United StatesGraduate Program in Oral and Craniofacial Sciences, School of Dentistry, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United StatesCenter for Regenerative and Personalized Medicine, The Steadman Philippon Research Institute (SPRI), Vail, CO, United StatesCenter for Regenerative and Personalized Medicine, The Steadman Philippon Research Institute (SPRI), Vail, CO, United StatesDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United StatesUC Berkeley—UCSF Graduate Program in Bioengineering, San Francisco, CA, United StatesDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United StatesUC Berkeley—UCSF Graduate Program in Bioengineering, San Francisco, CA, United StatesDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United StatesSchool of Dentistry, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Orthopaedic Surgery, Orthopaedic Trauma Institute, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Orthopaedic Surgery, Orthopaedic Trauma Institute, University of California, San Francisco (UCSF), San Francisco, CA, United StatesGraduate Program in Oral and Craniofacial Sciences, School of Dentistry, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Orthopaedic Surgery, Orthopaedic Trauma Institute, University of California, San Francisco (UCSF), San Francisco, CA, United StatesCenter for Regenerative and Personalized Medicine, The Steadman Philippon Research Institute (SPRI), Vail, CO, United StatesUC Berkeley—UCSF Graduate Program in Bioengineering, San Francisco, CA, United StatesGraduate Program in Oral and Craniofacial Sciences, School of Dentistry, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United StatesDepartment of Bioengineering, University of California, Berkeley (UC Berkeley), Berkeley, CA, United StatesSchool of Engineering, Brown University, Providence, RI, United StatesIntroduction: Currently, there are no non-surgical FDA-approved biological approaches to accelerate fracture repair. Injectable therapies designed to stimulate bone healing represent an exciting alternative to surgically implanted biologics, however, the translation of effective osteoinductive therapies remains challenging due to the need for safe and effective drug delivery. Hydrogel-based microparticle platforms may be a clinically relevant solution to create controlled and localized drug delivery to treat bone fractures. Here, we describe poly (ethylene glycol) dimethacrylate (PEGDMA)-based microparticles, in the shape of microrods, loaded with beta nerve growth factor (β-NGF) for the purpose of promoting fracture repair.Methods: Herein, PEGDMA microrods were fabricated through photolithography. PEGDMA microrods were loaded with β-NGF and in vitro release was examined. Subsequently, bioactivity assays were evaluated in vitro using the TF-1 tyrosine receptor kinase A (Trk-A) expressing cell line. Finally, in vivo studies using our well-established murine tibia fracture model were performed and a single injection of the β-NGF loaded PEGDMA microrods, non-loaded PEGDMA microrods, or soluble β-NGF was administered to assess the extent of fracture healing using Micro-computed tomography (µCT) and histomorphometry.Results:In vitro release studies showed there is significant retention of protein within the polymer matrix over 168 hours through physiochemical interactions. Bioactivity of protein post-loading was confirmed with the TF-1 cell line. In vivo studies using our murine tibia fracture model show that PEGDMA microrods injected at the site of fracture remained adjacent to the callus for over 7 days. Importantly, a single injection of β-NGF loaded PEGDMA microrods resulted in improved fracture healing as indicated by a significant increase in the percent bone in the fracture callus, trabecular connective density, and bone mineral density relative to soluble β-NGF control indicating improved drug retention within the tissue. The concomitant decrease in cartilage fraction supports our prior work showing that β-NGF promotes endochondral conversion of cartilage to bone to accelerate healing.Discussion: We demonstrate a novel and translational method wherein β-NGF can be encapsulated within PEGDMA microrods for local delivery and that β-NGF bioactivity is maintained resulting in improved bone fracture repair.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1190371/fullfracture repairendochondral ossificationbeta-nerve growth factordrug deliverysustained releasepoly (ethylene) glycol dimethacrylate
spellingShingle Kevin O. Rivera
Kevin O. Rivera
Kevin O. Rivera
Darnell L. Cuylear
Darnell L. Cuylear
Victoria R. Duke
Kelsey M. O’Hara
Justin X. Zhong
Justin X. Zhong
Nafisa A. Elghazali
Nafisa A. Elghazali
Joel A. Finbloom
Bhushan N. Kharbikar
Alex N. Kryger
Theodore Miclau
Ralph S. Marcucio
Chelsea S. Bahney
Chelsea S. Bahney
Chelsea S. Bahney
Chelsea S. Bahney
Tejal A. Desai
Tejal A. Desai
Tejal A. Desai
Tejal A. Desai
Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair
Frontiers in Bioengineering and Biotechnology
fracture repair
endochondral ossification
beta-nerve growth factor
drug delivery
sustained release
poly (ethylene) glycol dimethacrylate
title Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair
title_full Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair
title_fullStr Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair
title_full_unstemmed Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair
title_short Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair
title_sort encapsulation of β ngf in injectable microrods for localized delivery accelerates endochondral fracture repair
topic fracture repair
endochondral ossification
beta-nerve growth factor
drug delivery
sustained release
poly (ethylene) glycol dimethacrylate
url https://www.frontiersin.org/articles/10.3389/fbioe.2023.1190371/full
work_keys_str_mv AT kevinorivera encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT kevinorivera encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT kevinorivera encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT darnelllcuylear encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT darnelllcuylear encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT victoriarduke encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT kelseymohara encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT justinxzhong encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT justinxzhong encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT nafisaaelghazali encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT nafisaaelghazali encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT joelafinbloom encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT bhushannkharbikar encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT alexnkryger encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT theodoremiclau encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT ralphsmarcucio encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT chelseasbahney encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT chelseasbahney encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT chelseasbahney encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT chelseasbahney encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT tejaladesai encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT tejaladesai encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT tejaladesai encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair
AT tejaladesai encapsulationofbngfininjectablemicrorodsforlocalizeddeliveryacceleratesendochondralfracturerepair